Assistant Professor of Health Policy (NYU School of Medicine)
Dr. Makarov specializes in the treatment of prostate cancer and benign prostatic hyperplasia (BPH), as well as bladder and kidney cancer. He has first-hand experience in the surgical and medical treatment of prostate cancer. In addition to his clinical expertise in urological oncology, Dr. Makarov is a highly regarded health services researcher. He received his undergraduate degree in economics from Yale University and his medical degree at the Johns Hopkins School of Medicine. He completed a surgical internship in the William S. Halsted Department of Surgery and a residency in urology at the James Buchanan Brady Urological Institute (both at Johns Hopkins). After completing his residency, Dr. Makarov continued on the faculty at Johns Hopkins as an Instructor in Urology. After this experience, Dr. Makarov completed a Masters in Health Sciences Research as a Robert Wood Johnson Foundation Clinical Scholar at Yale University School of Medicine. Dr. Makarov joined NYU Urology Associates in 2010.
The goal of Dr. Makarov's research is to improve the quality and efficiency of care administered to men with prostate cancer in the United States. His research interests focus on the use of tissue and serum biomarkers for the risk stratification of men with prostate cancer (especially those with low-volume, low-grade disease) as well as policy-relevant questions impacting the provision of cost-effective, high-quality care for patients with prostate cancer. He is an Assistant Professor of Urology at the NYU School of Medicine as well as Assistant Professor of Health Policy at the Robert F. Wagner School of Public Service. Cognizant that many of the problems in the US healthcare system derive more from the inefficient delivery of care rather than a lack of available science, Dr. Makarov is interested in examining regional variation in utilization, appropriateness, and cost among problematic healthcare systems. In the future, Dr. Makarov hopes to leverage the understanding gained from studying such systems as multiple natural experiments in order to design large scale interventions to improve care.
In the Press
Hospitals Misleading Patients About Benefits of Robotic Surgery, Study Suggests